Raised CRP levels mark metabolic and functional impairment in advanced COPD

Broekhuizen, R.; Wouters, E. F. M.; Creutzberg, E. C.; Schols, A. M. W. J.
January 2006
Thorax;Jan2006, Vol. 61 Issue 1, p17
Academic Journal
Background: C-reactive protein (CRP) is often used as a clinical marker of acute systemic inflammation. Since low grade inflammation is evident in chronic diseases such as chronic obstructive pulmonary disease (COPD), new methods have been developed to enhance the sensitivity of CRP assays in the lower range. A study was undertaken to investigate the discriminative value of high sensitivity CRP in COPD with respect to markers of local and systemic impairment, disability, and handicap. Methods: Plasma CRP levels, interleukin 6 (IL-6) levels, body composition, resting energy expenditure (REE), exercise capacity, health status, and lung function were determined in 102 patients with clinically stable COPD (GOLD stage II-IV). The cut off point for normal versus raised CRP levels was 4.21 mg/l. Results: CRP levels were raised in 48 of 102 patients. In these patients, IL-6 (p<0.001) and REE (adjusted for fat-free mass, p=0.002) were higher while maximal (p=0.040) and submaximal exercise capacity (p=0.017) and 6 minute walking distance (p=0.014) were lower. The SGRO symptom score (p=0.003) was lower in patients with raised CRP levels, as were post-bronchodilator FEV1 (p=0.031) and reversibility (p =0.001). Regression analysis also showed that, when adjusted for FEV1, age and sex, CRP was a significant predictor for body mass index (p=0.044) and fat mass index (p=0.016). Conclusions: High sensitivity CRP is a marker for impaired energy metabolism, functional capacity, and distress due to respiratory symptoms in COPD.


Related Articles

  • High-Dose N-Acetylcysteine in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease. Zuin, R.; Palamidese, A.; Negrin, R.; Catozzo, L.; Scarda, A.; Balbinot, M. // Clinical Drug Investigation;2005, Vol. 25 Issue 6, p401 

    Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD). Design and patients: Randomised, double-blind, double-dummy, placebo-controlled study in 123 patients...

  • The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD). Garrod, Rachel; Marshall, Johanna; Barley, Elizabeth; Fredericks, Salim; Hagan, Gerry // Primary Care Respiratory Journal;Aug2007, Vol. 16 Issue 4, p236 

    Aims: To examine relationships between markers of systemic inflammation and functional status in patients with chronic obstructive pulmonary disease (COPD). Methods: 41 COPD patients were stratified using the Medical Research Council (MRC) dyspnoea scale. Six-minute walking distance (6MWD),...

  • Kronik obstruktif akciÄŸer hastalığı akut alevlenmeli hastalarda prokalsitonin ve diÄŸer akut faz belirteçleri. Civelek, Cemil; Korkmaz, İlhan; Eren, Şevki Hakan; Güven, Fatma Mutlu Kukul; Karadayı, Şule; Doğan, Ömer Tamer; Çınar, Ziynet; Beydilli, İnan // Dicle Medical Journal / Dicle Tip Dergisi;2011, Vol. 38 Issue 2, p137 

    Objectives: The aim of this study was to investigate the correlation between procalcitonin and other acute phase reactants, and also analyze their relationship with clinical situation in chronic obstructive pulmonary disease (COPD) acute exacerbations. Materials and methods: The study was made...

  • Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. Loza, Matthew J.; Watt, Rosemary; Baribaud, Frédéric; Barnathan, Elliot S.; Rennard, Stephen I. // Respiratory Research;Feb2012, Vol. 13 Issue 2, p1 

    Background: Chronic obstructive pulmonary disease (COPD) is characterized by progressive worsening of airflow limitation associated with abnormally inflamed airways in older smokers. Despite correlative evidence for a role for tumor necrosis factor-alpha in the pathogenesis of COPD, the...

  • Nutrition disorder and systemic inflammation in patients with chronic obstructive pulmonary disease. Ćirić, Zorica; Stanković, Ivana; Pejčić, Tatjana; Ristić, Lidija; Rančić, Milan; Radović, Milan; Nastasijević-Borovec, Desa // Medicinski Glasnik;Aug2013, Vol. 10 Issue 2, p266 

    Aim To detect nutrition disorders (underweight and obesity) in patients with chronic obstructive disease (COPD) and presence of systemic inflammation by determination of inflammatory mediators serum values C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α) and leptin. Methods The...

  • Serum C-reactive Protein Level and Distribution in Chronic Obstructive Pulmonary Disease Versus Healthy Controls: a Case-Control Study from Iran. Firouzjahi, Alireza; Monadi, Mahmoud; Karimpoor, Fatemeh; Heidari, Behzad; Dankoob, Yahya; Hajian-Tilaki, Karim; Firozjaii, Mokarraram // Inflammation;Oct2013, Vol. 36 Issue 5, p1122 

    Inflammation has a contributive role in the development and progression of chronic obstructive pulmonary disease (COPD).The present study was designed to determine the level and the distribution of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in COPD compared with controls....

  • Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial. MacNee, William; Allan, Richard J.; Jones, Ieuan; De Salvo, Maria Cristina; Tan, Lisa F. // Thorax;Aug2013, Vol. 68 Issue 8, p738 

    Rationale: Chronic obstructive pulmonary disease (COPD) is a common lung disease leading to progressive decline in lung function. Inhibition of release of inflammatory mediators by p38 inhibitors may be a useful treatment for chronic inflammation of the airways thought to underlie the...

  • Effects of rehabilitative exercise on peripheral muscle TNFα, IL-6, IGF-I and MyoD expression in patients with COPD. Vogiatzis, Ioannis; Stratakos, Grigoris; Simoes, Davina C. M.; Terzis, Gerasimos; Georgiadou, Olga; Roussos, Charis; Zakynthinos, Spyros // Thorax;Nov2007, Vol. 62 Issue 11, p950 

    Background: Skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (COPD) and has been associated with the presence of systemic inflammation. This study investigated whether rehabilitative exercise training decreases the levels of systemic or local muscle...

  • Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype. Agustí, Alvar; Edwards, Lisa D.; Rennard, Stephen I.; MacNee, William; Tal-Singer, Ruth; Miller, Bruce E.; Vestbo, Jørgen; Lomas, David A.; Calverley, Peter M. A.; Wouters, Emiel; Crim, Courtney; Yates, Julie C.; Silverman, Edwin K.; Coxson, Harvey O.; Bakke, Per; Mayer, Ruth J.; Celli, Bartolome // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in...


Read the Article


Sign out of this library

Other Topics